In AD also Aβ deposits in vascular endothelium inhibit the activity of endothelial nitric oxide synthase (eNOS), because of a PKC-mediated phosphorylation on Ser660, a key step in the activation of eNOS. Here, PRRT2 is linked to Alzheimer disease.